Pepcid vs. Pantoprazole
See how Pepcid and Pantoprazole compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Pepcid is an H2 blocker that starts working within about an hour, while pantoprazole is a PPI that can take a few days to reach full effect.
Pantoprazole gives longer-lasting acid suppression and higher healing rates for erosive esophagitis, but it needs a prescription in the U.S.
Pepcid is sold over the counter at lower doses, so it is easier to access for occasional heartburn without seeing a doctor first.
Pepcid vs. Pantoprazole Drug Summary
Pepcid
Pepcid (famotidine) is a histamine-2 (H2) blocker that reduces stomach acid production. It treats heartburn, GERD, ulcers, and erosive esophagitis, and is taken as a tablet once or twice daily depending on the condition.
Pantoprazole
Pantoprazole is a proton pump inhibitor (PPI) that blocks the stomach's acid pump for longer-lasting relief. It treats erosive esophagitis from GERD and Zollinger-Ellison syndrome, taken as a delayed-release tablet once or twice daily.
Pepcid vs. Pantoprazole Side Effects
Pepcid
Pantoprazole
Pepcid vs. Pantoprazole Dosage
Pepcid
Pantoprazole
| STAGE | DOSE | WHEN |
| Starting dose | 40 mg once daily | At the start |
| Maximum dose | 20 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 40 mg once daily | Weeks 1-8 |
| Maximum dose | 40 mg twice daily | If needed |
| Dose changes | 1 increase | As tolerated |
Pepcid
| STAGE | DOSE | WHEN |
| Starting dose | 40 mg once daily | At the start |
| Maximum dose | 20 mg once daily | If needed |
| Dose changes | 3 increases | As tolerated |
Pantoprazole
| STAGE | DOSE | WHEN |
| Starting dose | 40 mg once daily | Weeks 1-8 |
| Maximum dose | 40 mg twice daily | If needed |
| Dose changes | 1 increase | As tolerated |
Pepcid vs. Pantoprazole Indications
Pepcid
Pepcid is FDA-approved for short-term treatment of active duodenal and gastric ulcers, GERD, and erosive esophagitis, plus maintenance therapy for healed ulcers. It also treats pathological hypersecretory conditions such as Zollinger-Ellison syndrome.
Active duodenal ulcer (up to 8 weeks)
GERD (up to 6 weeks)
Erosive esophagitis (up to 12 weeks)
Pathological hypersecretory conditions
Pantoprazole
Pantoprazole is FDA-approved for short-term treatment of erosive esophagitis caused by GERD and for maintenance therapy once it has healed. It also treats pathological hypersecretory conditions like Zollinger-Ellison syndrome, but it is not approved for immediate heartburn relief.
Erosive esophagitis from GERD (short-term)
Maintenance of healed erosive esophagitis
Pathological hypersecretory conditions
Approved for pediatric use (age 5+)
Pepcid vs. Pantoprazole Pros and Cons
Pepcid
Pepcid has a well-established safety profile, a fast onset within about an hour, and is available over the counter at lower doses. It is generally less potent than a PPI, so it may not fully control severe or long-standing acid damage.
Pros
Starts working within about an hour
Available over the counter at lower doses
Fewer long-term risks with extended use
Simple once- or twice-daily dosing
Cons
Less potent acid suppression than a PPI
Shorter duration of action, about 12 hours
Lower healing rates for erosive esophagitis
Effects can lessen with regular long-term use
Pantoprazole
Pantoprazole provides stronger, longer-lasting acid suppression and higher healing rates for erosive esophagitis than an H2 blocker. It requires a prescription and carries added risks with extended use.
Pros
Stronger, more complete acid suppression
Acid control lasts up to 24 hours per dose
Higher healing rates for erosive esophagitis
Available as tablet, suspension, or IV
Cons
Requires a prescription in the U.S.
Can take several days for full symptom relief
Long-term use linked to fracture and B12 risks
Not intended for on-demand heartburn relief
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.